What is LOPJLB’s current signal on STLN?

LOPJLB’s latest quantitative signal on Starling Oncology, Inc. (STLN) is BUY in a BULL regime. Signals are updated daily.

What market regime is STLN in?

Starling Oncology, Inc. (STLN) is currently classified in the BULL HMM market regime on LOPJLB.

What does Starling Oncology, Inc. (STLN) do?

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans acros…

Where is Starling Oncology, Inc. based / listed?

Starling Oncology, Inc. is based in US, listed on NASDAQ.

Starling Oncology, Inc. (STLN)

COMPARE

Healthcare · Medical - Care Facilities · NASDAQ · US

$6.96+4.98%Close

BUYBULL · day 5

[SCORES & PROFILE]

FUND: 6
VALUE: 7
GROWTH: 31
GARP: 1
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC125.9%

REV YoY-

ROE209.8%

EPS YoY-

ROA-20.4%

GROSS

-4

NET

-6

[VALUATION]

P/E TTM-23.20

P/E FWD-

SECTOR PE22.28

INDUSTRY PE30.64

P/B-28.78

P/FCF-

EV/EBITDA-34.74

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO1.36

ND/EBITDA-

BETA0.44

Starling Oncology, Inc. (STLN)

Key stats

Prediction markets

FUNDAMENTALS

Company news